Rigel Pharmaceuticals, Inc.

... ...
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
BNGOBioNano Genomics, Inc. 30.29%12.770.0%$2627.57m
MRNAModerna, Inc. 10.15%144.320.0%$2549.08m
GILDGilead Sciences, Inc. -0.43%66.651.0%$646.90m
AMGNAmgen, Inc. -0.47%252.301.3%$561.92m
REGNRegeneron Pharmaceuticals, Inc. 1.75%547.212.7%$486.47m
CRSPCRISPR Therapeutics AG -1.25%186.140.6%$481.91m
ALXNAlexion Pharmaceuticals, Inc. 0.73%160.902.0%$474.03m
NVAXNovavax, Inc. 2.14%129.7092.9%$426.38m
ILMNIllumina, Inc. 1.20%411.143.5%$401.50m
VRTXVertex Pharmaceuticals, Inc. 0.95%239.851.9%$365.29m
SRPTSarepta Therapeutics, Inc. -1.72%96.5513.8%$358.52m
BIIBBiogen, Inc. 1.41%273.231.7%$326.42m
BNTXBioNTech SE 1.39%109.950.0%$302.49m
EXASEXACT Sciences Corp. 1.93%152.8919.6%$248.65m
PACBPacific Biosciences of California, Inc. -0.64%37.187.4%$226.70m

Company Profile

Rigel Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It discovers and develops novel, targeted drugs in the therapeutic areas of immunology, oncology and immune oncology. The firm focuses on intracellular signalling pathways and related targets that are critical to disease mechanisms. Its products include Tavalisse, Fostamatinib and R835. The company was founded by Donald G. Payan, James M. Gower, Thomas A. Raffin, Garry P. Nolan and Ronald B. Garren on June 14, 1996 and is headquartered in South San Francisco, CA.